Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.

Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Pendame R, Taylor TE, Molyneux ME.

Lancet. 2005 Jan 15-21;365(9455):233-40.

PMID:
15652606
2.

Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi.

Patnaik P, Jere CS, Miller WC, Hoffman IF, Wirima J, Pendame R, Meshnick SR, Taylor TE, Molyneux ME, Kublin JG.

J Infect Dis. 2005 Sep 15;192(6):984-91. Epub 2005 Aug 12.

PMID:
16107950
4.

The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women.

Mwapasa V, Rogerson SJ, Molyneux ME, Abrams ET, Kamwendo DD, Lema VM, Tadesse E, Chaluluka E, Wilson PE, Meshnick SR.

AIDS. 2004 Apr 30;18(7):1051-9.

PMID:
15096809
5.

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.

Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, Rogerson SJ, Kumwenda N, Eron JJ, Fiscus SA, Chakraborty H, Taha TE, Cohen MS, Molyneux ME.

AIDS. 1999 Mar 11;13(4):487-94.

PMID:
10197377
6.

CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria.

Van Geertruyden JP, Mulenga M, Kasongo W, Polman K, Colebunders R, Kestens L, D'Alessandro U.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):363-7.

PMID:
17079994
7.

Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.

Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.

AIDS. 2006 May 12;20(8):1117-23.

PMID:
16691062
9.

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC.

N Engl J Med. 2001 Mar 8;344(10):720-5.

10.

Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.

Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):42-9.

PMID:
8702036
11.

Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM.

Ann Intern Med. 2001 Dec 4;135(11):954-64.

PMID:
11730396
12.

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.

Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, Omoding N, Okongo M, Malamba S, Ojwiya A.

Lancet. 2000 Sep 23;356(9235):1051-6.

PMID:
11009139
13.

Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia.

Ariyoshi K, Schim van der Loeff M, Berry N, Jaffar S, Whittle H.

AIDS. 1999 Jun 18;13(9):1145-6. No abstract available.

PMID:
10397550
14.

Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.

Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; ATHENA national observational cohort and the MOSAIC study.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):536-42. doi: 10.1097/QAI.0000000000000514.

PMID:
25559595
15.

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

Schapiro JM, Winters MA, Stewart F, Efron B, Norris J, Kozal MJ, Merigan TC.

Ann Intern Med. 1996 Jun 15;124(12):1039-50.

PMID:
8633817
16.

CD4 count, viral load and parasite density of HIV positive individuals undergoing malaria treatment with dihydroartemisinin in Benin City, Edo state, Nigeria.

Tatfeng YM, Ihongbe JC, Okodua M, Oviasogie E, Isibor J, Tchougang S, Tambo E, Otegbeye T.

J Vector Borne Dis. 2007 Jun;44(2):111-5.

17.

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D; Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort.

Lancet Oncol. 2009 Dec;10(12):1152-9. doi: 10.1016/S1470-2045(09)70282-7. Epub 2009 Oct 7.

PMID:
19818686
18.

Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.

Valentine ME, Jackson CR, Vavro C, Wilfert CM, McClernon D, St Clair M, Katz SL, McKinney RE Jr.

Pediatr Infect Dis J. 1998 Jan;17(1):18-23.

PMID:
9469389
19.

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, Dyer WB, McIntyre L, Oelrichs RB, Rhodes DI, Deacon NJ, Sullivan JS.

N Engl J Med. 1999 Jun 3;340(22):1715-22.

20.

Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.

Smith PR, Sarner L, Murphy M, James B, Thomas JM, Skinner CJ, Aitken C.

J Clin Virol. 2003 Jan;26(1):101-7.

PMID:
12589840

Supplemental Content

Support Center